Changes in HbA1c, body weight, and systolic blood pressure in type 2 diabetes patients initiating dapagliflozin therapy: a primary care database study

Overview of attention for article published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, October 2016

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 18,802 followers.

Changes in HbA1c, body weight, and systolic blood pressure in T2D initiating dapagliflozin therapy https://t.co/GzHr1ZxVN1

Changes in HbA1c, body weight, and systolic blood pressure in T2D initiating dapagliflozin therapy https://t.co/tsoHHjuEkA

Changes in HbA1c, body weight, and systolic blood pressure in T2D initiating dapagliflozin therapy https://t.co/ZV8h3hX5uR

Changes in HbA1c, body weight, and systolic blood pressure in T2D initiating dapagliflozin therapy https://t.co/tPHmxjuiqI